MedPath

Enevital Capsule

Registration Number: MAL25026064NC

Approved
Approval ID

d679c23a749460d5

Registration Number

MAL25026064NC

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types5 types
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (5)

30 CapsulesAvailable
Package Size: 30 Capsules
Status: NPRA Approved
60 CapsulesAvailable
Package Size: 60 Capsules
Status: NPRA Approved
90 CapsulesAvailable
Package Size: 90 Capsules
Status: NPRA Approved
120 CapsulesAvailable
Package Size: 120 Capsules
Status: NPRA Approved
150 CapsulesAvailable
Package Size: 150 Capsules
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (2)

Pyrroloquinoline quinone disodium saltActive
Monograph: pyrroloquinoline quinone disodium salt
COENZYME Q10 (UBIDECARENONE)Active
Monograph: coenzyme q 10 (ubidecarenone)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Enevital Capsule - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform